Alex J Rai

Dr. Alex J Rai

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2020 in Laboratory Medicine
Verified
Journal Article
Closed access
MSMarie C Smithgall
Marie C Smithgall
MDMitra Dowlatshahi
Mitra Dowlatshahi
SSSteven L Spitalnik
Steven L Spitalnik
EHEldad A Hod
Eldad A Hod
ARAlex J Rai
Alex J Rai
Clinical laboratory testing routinely provides actionable results, which help direct patient care in the inpatient and outpatient settings. Since December 2019, a novel coronavirus (SARS-CoV-2) has been causing disease (COVID-19 [coronavirus disease 2019]) in patients, beginning in China and now extending worldwide. In this context of a novel viral pandemic, clinical laboratories have developed multiple novel assays for SARS-CoV-2 diagnosis and for managing patients afflicted with this illness. These include molecular and serologic-based tests, some with point-of-care testing capabilities. Herein, we present an overview of the types of testing available for managing patients with COVID-19, as well as for screening of potential plasma donors who have recovered from COVID-19.

6 January 2022 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
GAGrazia Ambrosini
Grazia Ambrosini
ARAlex J Rai
Alex J Rai
RCRichard D. Carvajal
Richard D. Carvajal
GSGary K. Schwartz
Gary K. Schwartz
Uveal melanoma is a rare melanoma subtype different from cutaneous melanoma, with high incidence of liver metastasis and poor prognosis. Cancer cell–derived extracellular vesicles have been shown to induce proinflammatory and prometastatic signaling in the tumor microenvironment and at distant sites. The characterization of uveal melanoma exosome cargo and its role in metastatic spread is essential to identify targets and intervene in the early stages of metastatic development. Our study characterizes the proteomic content of uveal melanoma exosomes and identified the presence of markers with metastatic properties. We demonstrated that uveal melanoma exosomes induce activation of cell signaling pathways and the release of cytokines and growth factors from hepatocytes. These exosome-stimulated liver cells could in turn induce migration of uveal melanoma cells, confirming that the exosomes have a functional role in the cross-talk between these two cell types. We found that the proinflammatory cytokine macrophage migration inhibitory factor (MIF) was a major player in these mechanisms and its blockade inhibited cell migration in coculture with exosome-stimulated hepatocytes and prevented the development of metastases in vivo. Targeting MIF in the early stages of metastasis may represent a novel adjuvant drug therapy to prevent metastatic spread in uveal melanoma. Implications: This study provides the first in vivo evidence that MIF inhibition may serve as a novel adjuvant drug therapy to prevent metastasis in uveal melanoma.

10 May 2023 in Mitochondrion
Verified
Journal Article
Closed access
JMJeremy Michelson
Jeremy Michelson
SRShannon Rausser
Shannon Rausser
APAmanda Peng
Amanda Peng
TYTemmie Yu
Temmie Yu
GSGabriel Sturm
Gabriel Sturm
MPMartin Picard
Martin Picard

20 October 2020 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
KOKenneth Ofori
Kenneth Ofori
GBGovind Bhagat
Govind Bhagat
ARAlex J Rai
Alex J Rai


27 October 2020 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
MWMaxwell D Weidmann
Maxwell D Weidmann
KOKenneth Ofori
Kenneth Ofori
ARAlex J Rai
Alex J Rai
Objectives: Laboratory testing and the measurement of appropriate biomarkers play a critical role in managing patients with coronavirus disease 2019 (COVID-19), allowing for disease diagnosis, monitoring progression, prognostication, prediction of treatment response, and risk stratification. We sought to characterize these effects on a more detailed, mechanistic level.Methods: We reviewed the literature and identified a multitude of reports that describe the unique effects of this virus and its devastating consequences to multiple organ systems in COVID-19 patients.Results: There are specific alterations in biomarkers related to coagulation, depopulation of T-cell subtypes, the cytokine storm and inflammation, and kidney and cardiac dysfunction.Conclusions: Laboratory measurement of specific parameters and the use of appropriate prognostic, predictive, and monitoring biomarkers afford clinicians the ability to make informed medical decisions and guide therapy for patients afflicted with this dreaded disease.